(Q48289650)

English

Disomy 1 with terminal 1p deletion is frequent in mass-screening-negative/late-presenting neuroblastomas in young children, but not in mass-screening-positive neuroblastomas in infants.

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

10 February 2018

http://europepmc.org/abstract/MED/9935230

Disomy 1 with terminal 1p deletion is frequent in mass-screening-negative/late-presenting neuroblastomas in young children, but not in mass-screening-positive neuroblastomas in infants. (English)

1 reference

Europe PubMed Central

10 February 2018

http://europepmc.org/abstract/MED/9935230

author name string

Y Kaneko

1

1 reference

Europe PubMed Central

10 February 2018

http://europepmc.org/abstract/MED/9935230

H Kobayashi

2

1 reference

Europe PubMed Central

10 February 2018

http://europepmc.org/abstract/MED/9935230

N Maseki

3

1 reference

Europe PubMed Central

10 February 2018

http://europepmc.org/abstract/MED/9935230

A Nakagawara

4

1 reference

Europe PubMed Central

10 February 2018

http://europepmc.org/abstract/MED/9935230

M Sakurai

5

1 reference

Europe PubMed Central

10 February 2018

http://europepmc.org/abstract/MED/9935230

language of work or name

0 references

publication date

1 January 1999

1 reference

Europe PubMed Central

10 February 2018

http://europepmc.org/abstract/MED/9935230

number of pages

6

1 reference

based on heuristic

inferred from page(s)

International Journal of Cancer

1 reference

Europe PubMed Central

10 February 2018

http://europepmc.org/abstract/MED/9935230

80

1 reference

Europe PubMed Central

10 February 2018

http://europepmc.org/abstract/MED/9935230

54-59

1 reference

Europe PubMed Central

10 February 2018

http://europepmc.org/abstract/MED/9935230

1

1 reference

Europe PubMed Central

10 February 2018

http://europepmc.org/abstract/MED/9935230

A comprehensive genetic map of the human genome based on 5,264 microsatellites

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0215%2819990105%2980%3A1%3C54%3A%3AAID-IJC11%3E3.0.CO%3B2-G

21 January 2018

A proposed staging for children with neuroblastoma.Children's cancer study group A

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0215%2819990105%2980%3A1%3C54%3A%3AAID-IJC11%3E3.0.CO%3B2-G

21 January 2018

Cytogenetic findings and prognosis in neuroblastoma with emphasis on marker chromosome 1.

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0215%2819990105%2980%3A1%3C54%3A%3AAID-IJC11%3E3.0.CO%3B2-G

21 January 2018

Nonparametric Estimation from Incomplete Observations

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0215%2819990105%2980%3A1%3C54%3A%3AAID-IJC11%3E3.0.CO%3B2-G

21 January 2018

Neuroblastoma screening in infants postponed after the sixth month of age: a trial to reduce "overdiagnosis" and to detect cases with "unfavorable" biologic features

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0215%2819990105%2980%3A1%3C54%3A%3AAID-IJC11%3E3.0.CO%3B2-G

21 January 2018

Transposition and amplification of oncogene-related sequences in human neuroblastomas

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0215%2819990105%2980%3A1%3C54%3A%3AAID-IJC11%3E3.0.CO%3B2-G

21 January 2018

Association between high levels of expression of the TRK gene and favorable outcome in human neuroblastoma

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0215%2819990105%2980%3A1%3C54%3A%3AAID-IJC11%3E3.0.CO%3B2-G

21 January 2018

Screening for neuroblastoma in the north of England

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0215%2819990105%2980%3A1%3C54%3A%3AAID-IJC11%3E3.0.CO%3B2-G

21 January 2018

Mass screening for neuroblastoma in infants in Japan. Interim report of a mass screening study group

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0215%2819990105%2980%3A1%3C54%3A%3AAID-IJC11%3E3.0.CO%3B2-G

21 January 2018

Treatment of advanced neuroblastoma with emphasis on intensive induction chemotherapy. A report from the Study Group of Japan.

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0215%2819990105%2980%3A1%3C54%3A%3AAID-IJC11%3E3.0.CO%3B2-G

21 January 2018

An increased NM23H1 copy number may be a poor prognostic factor independent of LOH on 1p in neuroblastomas

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0215%2819990105%2980%3A1%3C54%3A%3AAID-IJC11%3E3.0.CO%3B2-G

21 January 2018

Mass screening and age-specific incidence of neuroblastoma in Saitama Prefecture, Japan.

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0215%2819990105%2980%3A1%3C54%3A%3AAID-IJC11%3E3.0.CO%3B2-G

21 January 2018

Screening for neuroblastoma: a 9-year birth cohort-based study in Niigata, Japan

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0215%2819990105%2980%3A1%3C54%3A%3AAID-IJC11%3E3.0.CO%3B2-G

21 January 2018

Allelic loss of chromosome 1p as a predictor of unfavorable outcome in patients with neuroblastoma

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0215%2819990105%2980%3A1%3C54%3A%3AAID-IJC11%3E3.0.CO%3B2-G

21 January 2018

Clinical impact of chromosome 1 aberrations in neuroblastoma: a metaphase and interphase cytogenetic study

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0215%2819990105%2980%3A1%3C54%3A%3AAID-IJC11%3E3.0.CO%3B2-G

21 January 2018

Current urinary mass screening for catecholamine metabolites at 6 months of age may be detecting only a small portion of high-risk neuroblastomas: a chromosome and N-myc amplification study

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0215%2819990105%2980%3A1%3C54%3A%3AAID-IJC11%3E3.0.CO%3B2-G

21 January 2018

The der(21)t(12;21) chromosome is always formed in a 12;21 translocation associated with childhood acute lymphoblastic leukaemia

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0215%2819990105%2980%3A1%3C54%3A%3AAID-IJC11%3E3.0.CO%3B2-G

21 January 2018

Clinical relevance of tumor cell ploidy and N-myc gene amplification in childhood neuroblastoma: a Pediatric Oncology Group study

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0215%2819990105%2980%3A1%3C54%3A%3AAID-IJC11%3E3.0.CO%3B2-G

21 January 2018

Spontaneous regression of neuroblastoma detected by mass screening

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0215%2819990105%2980%3A1%3C54%3A%3AAID-IJC11%3E3.0.CO%3B2-G

21 January 2018

Different genomic and metabolic patterns between mass screening-positive and mass screening-negative later-presenting neuroblastomas

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0215%2819990105%2980%3A1%3C54%3A%3AAID-IJC11%3E3.0.CO%3B2-G

21 January 2018

Mass screening for neuroblastoma and mortality in birth cohorts

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0215%2819990105%2980%3A1%3C54%3A%3AAID-IJC11%3E3.0.CO%3B2-G

21 January 2018

Treatment combined with bone marrow transplantation for advanced neuroblastoma: an analysis of patients who were pretreated intensively with the protocol of the Study Group of Japan

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0215%2819990105%2980%3A1%3C54%3A%3AAID-IJC11%3E3.0.CO%3B2-G

21 January 2018

Asymptotically Efficient Rank Invariant Test Procedures

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0215%2819990105%2980%3A1%3C54%3A%3AAID-IJC11%3E3.0.CO%3B2-G

21 January 2018

There may be two tumor suppressor genes on chromosome arm 1p closely associated with biologically distinct subtypes of neuroblastoma

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0215%2819990105%2980%3A1%3C54%3A%3AAID-IJC11%3E3.0.CO%3B2-G

21 January 2018

A population-based study of the usefulness of screening for neuroblastoma

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0215%2819990105%2980%3A1%3C54%3A%3AAID-IJC11%3E3.0.CO%3B2-G

21 January 2018

Natural history of neuroblastoma found by mass screening

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0215%2819990105%2980%3A1%3C54%3A%3AAID-IJC11%3E3.0.CO%3B2-G

21 January 2018

Identifiers

10.1002/(SICI)1097-0215(19990105)80:1<54::AID-IJC11>3.0.CO;2-G

1 reference

Europe PubMed Central

10 February 2018

http://europepmc.org/abstract/MED/9935230

1 reference

Europe PubMed Central

10 February 2018

http://europepmc.org/abstract/MED/9935230

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q48289650&oldid=1775036004"